Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-05-19 @ 1:54 PM
Study NCT ID:
NCT05862233
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-20
First Post:
2023-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy
Sponsor:
Beijing Mabworks Biotech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MIL62-CT307
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None